Learn about Pneumonia: Facts, Figures and What You Can Do [link fixed]
Pneumonia Innovation Summit proceedings 2015
Preventing Pneumonia – CDC resource (USA): in the USA, pcv-13 vaccine is used initially to optimise the immunogenicity of subsequent 23-valent polysaccharide vaccine dose (Australia does not currently recommend this approach – repeat doses, 5 years apart to a maximum of three are recommended ).
Recent review of pneumococcal vaccination. Systematic review of 23v vaccine repeat dosing – some support for impact.
Some staggering childhood pneumonia statistics: